J Thymis

National and Kapodistrian University of Athens — Greece

Medicine · Health Sciences

13h-index797citations136works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular Health and Disease Prevention(48), Blood Pressure and Hypertension Studies(30), Cardiovascular Function and Risk Factors(26), Diabetes Treatment and Management(24), Trauma, Hemostasis, Coagulopathy, Resuscitation(15)

Publications136 total

MiniMed <sup>TM</sup> 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics
Diabetes Technology & Therapeutics·2026
Vascular and Myocardial Function in Patients with Type 2 Diabetes and Ischemic Stroke Treated with Dulaglutide or Empagliflozin
Medicina·2026Open Access
GLP-1 receptor agonists, SGLT-2 inhibitors, and their combination: effects on carotid atherosclerosis regression, oxidative stress, and amyloid-β1–40 in diabetes
American Journal of Physiology-Heart and Circulatory Physiology·2026
The Beneficial Effects of Combination Therapy With SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
Current Diabetes Reviews·2026
Association of elevated lipoprotein(a) levels with impaired arterial elasticity and endothelial glycocaclyx
European Heart Journal - Cardiovascular Imaging·2026
Impact of olive oil extracts in myocardial and vascular function of patients with chronic cononary syndromes
European Heart Journal - Cardiovascular Imaging·2026
Impact of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on myocardial work and coronary flow in liver steatosis and diabetes
European Heart Journal - Cardiovascular Imaging·2026
Effect of a 12-month treatment with liraglutide, empagliflozin and their combination on carotid intima-media thickness in patients with type 2 diabetes mellitus
European Heart Journal·2025
The effect of 4-month treatment with glycocalyx dietary supplement on endothelial glycocalyx integrity and vascular function in patients with psoriasis
European Heart Journal·2025
Endothelial glycocalyx integrity of the sublingual microvessels as a predictor of left ventricular performance following STEMI: a 12-month study
European Heart Journal·2025
Improvement of endothelial glycocalyx thickness is associated improvement of arterial elasticiy in STEMI patients after smoking cessation
European Heart Journal·2025
Twelve-month treatment with glucagon-like peptide-1 receptor agonists or sodium-glucose co-transporter-2 inhibitors improves arterial function and myocardial deformation after ischemic stroke
European Heart Journal·2025
The effects of cytisinicline for smoking cessation on arterial stiffness, endothelial function and myocardial performance: a pilot study
European Heart Journal·2025
Effect of sacubitril/valsartan or enalapril on left ventricular function in patients with hematologic malignancies treated with bone marrow transplantation
European Heart Journal Supplements·2025
Association of Endothelial Glycocalyx Integrity with Left Ventricular Performance and Remodeling after Acute Myocardial Infarction: A 12-month Follow-up Study
Thrombosis and Haemostasis·2025
Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS)
International Journal of Molecular Sciences·2025· 2 citedOpen Access
Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review
Journal of Clinical Medicine·2025· 12 citedOpen Access
The effect of treatment on matrix metalloproteinases levels and endothelial function in women with polycystic ovary syndrome. association with metabolic and hormonal abnormalities of the syndrome
Endocrine Abstracts·2025
Effects of 4‐month treatment with glycocalyx dietary supplement on endothelial glycocalyx and vascular function after COVID‐19 infection
European Journal of Clinical Investigation·2025Open Access
Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes
Journal of the American Heart Association·2025· 5 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Ignatios Ikonomidis(50), Κ Katogiannis(37), Vaia Lambadiari(36), George Pavlidis(31), Aikaterini Kountouri(27), G Kostelli(25), John Parissis(17), Emmanouil Korakas(17), Ioanna Andreadou(14), Loukia Pliouta(12), Helen Triantafyllidi(10), Evangelia Papadavid(10), D Tsilivarakis(10), Dimitrios Vlastos(10), Foteini Kousathana(9), Maria Tsoumani(9), George Makavos(8), Stamatios Lampsas(8), Konstantinos Theodoropoulos(7), Pelagia Katsimbri(7)